Stem Cell Reports Named Official Meeting Journal for ASSCR 2026 in Melbourne

The Australasian Society for Stem Cell Research has announced that Stem Cell Reports, the official journal of the International Society for Stem Cell Research, will serve as the Official Meeting Journal of the ASSCR 2026 Annual Scientific Meeting. The conference is scheduled to take place from 9 to 11 November 2026 at The Glasshouse in Melbourne, Australia, and will convene stem cell biologists, clinician-scientists, and early-career investigators from across the Australasian region and the wider international community. The designation reflects a growing pattern of collaboration between scientific societies and the journals that publish their fields’ most consequential findings, and it positions the meeting’s scientific output within one of the most widely read open access venues in stem cell research.

Under the theme Brewing Innovation, ASSCR 2026 is designed to bring together researchers and leaders in stem cell science and regenerative medicine to share new discoveries, explore emerging technologies, and foster scientific collaboration across the Australasian research community and beyond. The theme signals an emphasis on novel approaches, whether in pluripotent stem cell derivation, organoid modeling, gene editing, or translational cell therapy development. Meetings of this kind play a critical role in the scientific ecosystem: they provide the first public airing of results that may take months or years to appear in final published form, they create structured opportunities for early-career scientists to present work to senior figures in the field, and they seed the multi-institutional collaborations that increasingly define large-scale biomedical research.

As the Official Meeting Journal, Stem Cell Reports reinforces its stated commitment to supporting the global stem cell research community and promoting the dissemination of rigorous, high-quality research. The journal publishes work spanning the full arc of the discipline, from fundamental discoveries in developmental and stem cell biology through translational and clinical applications, providing an international platform for scientific advances and perspectives that are shaping the future of the field. In practical terms, the partnership means that the science presented in Melbourne will be connected to a journal whose editorial standards and open access model are already familiar to the meeting’s attendees, many of whom publish, review, or cite the journal as part of their regular research practice.

The collaboration also carries concrete benefits for individual researchers. Stem Cell Reports will provide complimentary International Society for Stem Cell Research memberships for up to two winners of the ASSCR Mid-Career Researcher Award, a form of support that connects Australasian investigators to the largest global professional network in the discipline. In addition, the journal will host a co-branded webinar in 2027 showcasing the research of those award winners, extending the visibility of their work well beyond the three days of the meeting itself. Together, these activities are intended to amplify the meeting’s reach, recognize scientific excellence, and create opportunities for continued engagement and knowledge exchange after the conference concludes.

Stem Cell Reports occupies a distinctive position in the scientific publishing landscape. It is the open access, peer-reviewed journal of the International Society for Stem Cell Research, established to communicate basic discoveries in stem cell research alongside translational and clinical studies. The journal focuses on original research that delivers conceptual or practical advances of broad interest to stem cell biologists and clinicians, a scope that deliberately bridges the laboratory and the clinic. It operates as a Cell Press partner journal, which places it within a publishing ecosystem that includes some of the most visible titles in the life sciences, and it maintains an active presence on the social platform X under the handle @StemCellReports. Its open access model means that published findings, including those connected to society meetings, are freely readable by researchers, clinicians, students, and the public worldwide.

The International Society for Stem Cell Research itself is the preeminent global, cross-disciplinary, science-based organization dedicated to advancing stem cell research and its translation to medicine. Active across more than 80 countries, the society sets standards for rigor and ethics in the field, convenes an annual international meeting that draws thousands of attendees, and advocates for responsible policies governing stem cell science. For a regional society such as the ASSCR, aligning its flagship annual meeting with the ISSCR’s official journal creates a formal channel between local research excellence and the international infrastructure that disseminates and validates it. The arrangement underscores how modern scientific societies increasingly operate as interconnected networks rather than isolated national bodies.

The timing and location of the 2026 meeting carry their own significance. Melbourne has long been recognized as a hub of Australian biomedical research, home to major medical research institutes, universities, and clinical programs with deep strengths in developmental biology, regenerative medicine, and stem cell technology. Hosting the meeting at The Glasshouse from 9 to 11 November 2026 places Australasian researchers at the center of a concentrated exchange of ideas at a moment when the field is moving rapidly from foundational discovery toward clinical application. Sessions are expected to reflect that trajectory, with the Brewing Innovation theme encouraging presentations on the technologies and conceptual breakthroughs that are redefining what stem cell science can achieve.

For the ASSCR, the partnership with Stem Cell Reports represents more than a symbolic endorsement. Scientific meetings depend on the promise that the work presented will find a durable, credible home in the literature, and journals depend on societies to surface the strongest new findings and the researchers producing them. By naming an Official Meeting Journal, the society formalizes that reciprocal relationship. Award winners gain global visibility through complimentary society memberships and a dedicated 2027 webinar, while the journal gains direct engagement with a vibrant regional community whose work spans fundamental stem cell biology, disease modeling, drug discovery platforms, and emerging cell-based therapies. The result is a pipeline that carries Australasian discoveries from conference podium to international readership.

The broader context for this announcement is a field in the midst of accelerated maturation. Induced pluripotent stem cell technology continues to expand the possibilities for patient-specific disease modeling and personalized drug testing. Organoid systems are recreating increasingly complex aspects of human organ development and function in the laboratory. Gene editing tools are being combined with stem cell platforms to correct disease-causing variants before cells are used therapeutically. Clinical trials of cell therapies are progressing across ophthalmology, neurology, cardiology, and diabetes. Each of these advances depends on rigorous, openly accessible publication of methods and results, which is precisely the role that society-affiliated journals such as Stem Cell Reports are designed to fulfill. A meeting journal partnership therefore connects the conference floor directly to the permanent scientific record.

As the 9 to 11 November 2026 dates approach, the ASSCR and Stem Cell Reports are expected to share further details about the scientific program, abstract submission, award nominations, and registration through the society’s official channels. For researchers in Australia, New Zealand, and the wider Asia-Pacific region, the meeting offers an annual anchor point for the community, and the 2026 edition, backed by the Official Meeting Journal designation and the Brewing Innovation theme, is positioned to showcase the region’s contributions to one of biomedicine’s most dynamic disciplines. For the international readership of Stem Cell Reports, the partnership promises a steady flow of rigorous new work from Australasian laboratories, reinforcing the journal’s mission of communicating the discoveries that are shaping the future of stem cell science and regenerative medicine worldwide.

Subject of Research: Designation of Stem Cell Reports as the official meeting journal of the Australasian Society for Stem Cell Research 2026 Annual Scientific Meeting

Article Title: Stem Cell Reports named official meeting Journal of ASSCR 2026 Annual Scientific Meeting

Article References: Stem Cell Reports named official meeting Journal of ASSCR 2026 Annual Scientific Meeting. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: Stem Cell Reports, ASSCR, ISSCR, stem cell research, regenerative medicine, scientific meeting, Melbourne, open access publishing, Cell Press, Mid-Career Researcher Award, Australasia, scientific collaboration